ITRACONAZOLE

FUNGIVICE

COMPOSITON
ITRACONAZOLE100MG /200MG
SPECIFICATION
FORMCAPSULECAPSULE
PACKING10X410X1X4
PACKING TYPECAPSULECAPSULE
MRP750 | 10001250

DESCRIPTION

One of the triazole antifungal agents that inhibits cytochrome P-450-dependent enzymes resulting in impairment of ergosterol synthesis. It has been used against histoplasmosis, blastomycosis, cryptococcal meningitis & aspergillosis. [PubChem]

SIDE EFFECTS

For the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: pulmonary and extrapulmonary blastomycosis, histoplasmosis, aspergillosis, and onychomycosis.

INDICATION